Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

Featuring perspectives from Dr Christine L Hann and Dr Jacob Sands, including the following topics:

• Introduction: Biopharmacology of Small Cell Lung Cancer — "Wildfire sparked in dry grass" (0:00)
• Limited-Stage Disease (9:22)
• Extensive-Stage Disease (16:23)
• Paraneoplastic Syndromes — Lambert-Eaton Myasthenic Syndrome (23:54)
• Bispecific T-Cell Engagers — Tarlatamab (30:00)
• Antibody-Drug Conjugates — Ifinatamab Deruxtecan (39:19)
• Other Novel Agents — Alisertib, Chimeric Antigen Receptor T-Cell Therapy (52:54)

CME information and select publications